Metabolic Solutions Development Company Appoints Robert L. Zerbe, MD to Board of Managers

KALAMAZOO, Mich., October 23, 2014 – Metabolic Solutions Development Company, LLC (MSDC) announced today that it has appointed Robert L. Zerbe, MD to its Board of Managers. Dr. Zerbe co-founded and is chief executive officer of QuatRx Pharmaceuticals Company, a venture-backed drug development company that developed the recently launched product for postmenopausal dyspareunia, Osphena®. Prior to QuatRx, he served as Senior Vice President of Worldwide Clinical Research and Development of Pfizer (formerly Parke-Davis), where he led the clinical development programs for Neurontin® and Lipitor®.

Read more:  Metabolic Solutions Development Company Appoints Robert L. Zerbe, MD to Board of Managers